Medicine
How to stop our immune systems from turning on us
From "inverse vaccines" to repurposed cancer therapies, several potential cures for autoimmune diseases are showing serious promise.
New hope for early pancreatic cancer intervention via AI-based risk prediction
To train their machine learning models, MIT researchers used electronic health record data from various institutions across the U.S.
One-shot CRISPR treatment for inherited disease aces first human trial
A CRISPR treatment for hereditary angioedema significantly reduced swelling attacks in its first human trial.
New non-opioid pain reliever moves closer to approval
Vertex Pharmaceuticals’ new painkiller, VX-548, significantly reduced moderate-to-severe pain in two phase 3 trials.
Inhalable sensors could enable early lung cancer detection
MIT engineers have designed diagnostic particles that can be aerosolized and inhaled to find cancer-associated proteins in the lungs.
Anti-aging pill for senior dogs is now in clinical trials
An anti-aging pill for senior dogs now in clinical trials might lead to treatments that extend human lives, too.
New antiviral shortens COVID-19 by 1.5 days
People taking simnotrelvir, a new antiviral treatment for COVID-19, felt almost immediate symptom relief and got better 1.5 days faster.
A dietician explains “Zepbound,” the newest weightloss drug
Zepbound recently joined the list of obesity-fighting drugs administered as injections that has been approved by the FDA.
One-and-done anti-aging treatment “rejuvenates” old mice
CAR-T cells that have been modified to target senescent cells could be a one-and-done anti-aging treatment.
Drinking this foam could boost an experimental cancer therapy
A drinkable foam packed with carbon monoxide molecules appears to boost the cancer-killing effects of autophagy inhibitors.